Company / Tangible Book Value per Share
AVADEL PHARMACEUTICALS PLC Tangible Book Value per Share History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Tangible Book Value per Share
$0.60
FY2024
5-year range
-$0.63 / $2.65
FY2020-FY2024
Trend
-32.2%
vs FY2023
Sector context
#171 of 209
Health Care
What the data says
AVADEL PHARMACEUTICALS PLC's tangible book value per share of $0.60 is lower than 82% of companies in the Health Care sector (FY2024). Tangible Book Value per Share has fluctuated over the past 10 years, ranging from $-1.28 in FY2019 to $2.65 in FY2020.
Based on SEC 10-K filings.
0.60 in FY2024 with a 3-year CAGR of -17.0%.
Improved from $-0.63 to $0.60 over the past 2 years.
Health Care sector context is included.
Tangible Book Value per Share over time
Growth rates
- 3-Year CAGR
- -17.0%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
-99.4% below sector average
Key checks
Key Insights
- In FY2024, tangible book value per share decreased 32.2% year-over-year.
- Ranks #171 out of 209 companies in the Health Care sector.
- Peak tangible book value per share was recorded in FY2020.
- Lowest tangible book value per share in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score 0.94 (distress zone, below 1.8 threshold)
- Negative profit margin: -28.9%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Tangible Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $0.60 | -32.2% |
| FY2023 | $0.88 | +239.9% |
| FY2022 | -$0.63 | -160.2% |
| FY2021 | $1.05 | -60.4% |
| FY2020 | $2.65 | +307.6% |
| FY2019 | -$1.28 | -202.9% |
| FY2018 | -$0.42 | -126.2% |
| FY2017 | $1.61 | +181.0% |
| FY2016 | $0.57 | -50.8% |
| FY2015 | $1.16 | +543.5% |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026